Spain’s Almirall in Talks With Dozens of Firms to License China Assets, CEO Says

Spain’s pharmaceutical leader Almirall is making waves in the global health sector. The company has publicly confirmed that it is in active talks with dozens of firms in China. The goal? To license China‑based medicines and assets to partners who can help commercialize them beyond the local market. This comes as the company strengthens its focus on medical dermatology and global growth.